Allogene Therapeutics, Inc. · NASDAQ:ALLO
Arie Belldegrun, M.D. reported a 5.60% stake in Allogene Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 13, 2025
Arie Belldegrun, M.D. reported a 5.60% stake in Allogene Therapeutics, Inc., 12,668,344 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).
- Stake
- 5.60%
- Shares
- 12,668,344
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Arie Belldegrun, M.D. | 5.60% | 12,668,344 |
| Bellco Legacy LLC | 0.20% | 539,867 |
| Bellco Legacy IV LLC | 2.10% | 4,710,120 |
| Vida Ventures LLC | 0.80% | 1,798,163 |
| Vida Ventures III, L.P. | 0.80% | 1,720,172 |
| Vida Ventures III-A, L.P. | 0% | 3,965 |
Source
Related
- Allogene Therapeutics, Inc.
- Arie Belldegrun, M.D.
- Allogene Therapeutics, Inc. shareholders
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 7, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · May 13, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Feb 17, 2026
- Schedule 13G/A · Arie Belldegrun, M.D. · Aug 12, 2025
- Schedule 13G/A · Arie Belldegrun, M.D. · May 9, 2025
- Form 4 · Parker Geoffrey M. · Oct 23, 2026
- Schedule 13D/A · Tpg Gp A, LLC · Sep 30, 2026
- Form 4 · Douglas Earl Martin · Aug 25, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026